Skip to main content
SpringerLink
Log in

Skin and Connective Tissue Disorders

  • Chapter
Book cover Molecular Pathology in Clinical Practice

  • 1958 Accesses

Abstract

Osteogenesis imperfecta (OI) is a clinically heterogeneous disorder resulting from the reduced synthesis or the accumulation of abnormal type I collagen, which is a major structural component of many connective tissues including bone. Type I collagen is a trimeric molecule composed of two α1(I) chains and one α2(I) chain, encoded by the COL1A1 and COL1A2 genes, respectively. Fibrillar collagens have a long triple helical domain composed of Gly-X-Y repeats. Glycine residues at every third position are required for the formation of the triple helical domain.1 OI is predominantly inherited in an autosomal dominant fashion and is caused by a wide variety of mutational events in either the COL1A1 or COL1A2 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kielty CM, Grant ME. The collagen family: structure, assembly, and organization in the extracellular matrix. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:159–221.

    Google Scholar 

  2. Silence D. Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop. 1981;159:11–25.

    Google Scholar 

  3. Byers PH, Cole WG. Osteogenesis imperfecta. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:358–430.

    Google Scholar 

  4. Körkkö J, Ala-Kokko L, De Paepe AD, et al. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformational-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null allele mutations. Am J Hum Genet. 1998;62:98–110.

    Article  PubMed  Google Scholar 

  5. Bruckner-Tuderman L. Epidermolysis bullosa. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:687–725.

    Google Scholar 

  6. Pulkkinen L, Uitto J. Mutational analysis and molecular genetics of epidermolysis bullosa. Matrix Biol. 1999;18:29–42.

    Article  PubMed  CAS  Google Scholar 

  7. Uitto J, Pulkkinen L. Molecular genetics of heritable blistering disorders. Arch Dermatol. 2001;137:1458–1462.

    PubMed  CAS  Google Scholar 

  8. Cserhalmi-Friedman PB, Tang Y, Adler A, et al. Preimplantation genetic testing in two families at risk for recurrence of Herlitz junctional epidermalolysis bullosa. Exp Dermatol. 2000;9:290–297.

    Article  PubMed  CAS  Google Scholar 

  9. Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:431–523.

    Google Scholar 

  10. Schalkwijk J, Zweers MC, Steijlen PM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med. 2001;345:1167–1175.

    Article  PubMed  CAS  Google Scholar 

  11. Schwarze U, Atkinson M, Hoffman GG, et al. Null alleles of the COL5A1 gene of type V collagen are a cause of the classic forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet. 2000;66:1757–1765.

    Article  PubMed  CAS  Google Scholar 

  12. Pepin M, Schwarze U, Superti-Furga A, et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–680.

    Article  PubMed  CAS  Google Scholar 

  13. Pepin MG, Byers PH. Ehlers-Danlos syndrome, vascular type. GeneReviews [database online]. 1999. Available at: http://www.genetests.org. Updated 2002.

    Google Scholar 

  14. Schwarze U, Goldstein JA, Byers PH. Splicing defects in the COL3A1 gene: marked preference for 5′ (donor) splice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet. 1997;61:1276–1278.

    Article  PubMed  CAS  Google Scholar 

  15. Schwarze U, Schievink WI, Petty E, et al. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome type IV. Am J Hum Genet. 2001;69:989–1001.

    Article  PubMed  CAS  Google Scholar 

  16. Hyland J, Ala-Kokko L, Royce P, et al. A homozygous stop codon in the lysyl hydroxylase gene in a family with Ehlers-Danlos syndrome type VI. Nat Genet. 1992;2:228–231.

    Article  PubMed  CAS  Google Scholar 

  17. Yeowell HN, Walker LC. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol Genet Metab. 2000;71:212–224.

    Article  PubMed  CAS  Google Scholar 

  18. Byers PH, Duvic M, Atkinson M. Ehlers-Danlos syndrome typeVIIA and type VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet. 1997;72:94–105.

    Article  PubMed  CAS  Google Scholar 

  19. Horton WA, Hecht JT. Chondrodysplasias: disorders of cartilage matrix proteins. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:909–937.

    Google Scholar 

  20. Superti-Furga A. Skeletal dysplasias related to defects in sulfate metabolism. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:939–960.

    Google Scholar 

  21. Rossi A, Superti-Furga A. Mutations in the diastrophic sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Hum Mutat. 2001;17:159–171.

    Article  PubMed  CAS  Google Scholar 

  22. Körkkö J, Kaitila I, Lönnqvist L, et al. Sensitivity of conformational sensitive gel electrophoresis in detecting mutations in Marfan-syndrome and related conditions. J Med Genet. 2002;39:34–41.

    Article  PubMed  Google Scholar 

  23. Pyeritz RE, Dietz HC. Marfan syndrome and other microfibrillar disorders. In: Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders. 2nd ed. New York: Wiley-Liss; 2002:585–626.

    Google Scholar 

  24. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Hum Genet. 1996;62:417–426.

    Google Scholar 

  25. Milewicz DM, Zsolt U, Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol. 2000;19:471–480.

    Article  PubMed  CAS  Google Scholar 

  26. Handford PA, Downing AK, Reinhardt DP, et al. Fibrillin: from domain to supramolecular assembly. Matrix Biol. 2000;19:457–470.

    Article  PubMed  CAS  Google Scholar 

  27. Robinson PN, Booms P, katzke S, et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat. 2002;20:153–161.

    Article  PubMed  CAS  Google Scholar 

  28. Katzke S, Booms P, Tiecke F, et al. TGGE screening of the entire FBN1 coding sequence in 126 individuals with Marfan syndrome and related fibrillinopathies. Hum Mutat. 2002;20:197–208.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Connective Tissue Gene Tests, Allentown, PA, 18103

    James C. Hyland MD, PhD (Medical Director and CEO and Hematopathologist)

  2. Health Network Laboratories and Lehigh Valley Hospital, Allentown, PA, 18103, USA

    James C. Hyland MD, PhD (Medical Director and CEO and Hematopathologist)

Authors
  1. James C. Hyland MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY, 10021, USA

    Debra G. B. Leonard MD, PhD (Professor and Vice Chair for Laboratory Medicine) (Professor and Vice Chair for Laboratory Medicine)

  2. Hematology, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA

    Adam Bagg MD (Director) (Director)

  3. Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA, 30322, USA

    Angela M. Caliendo MD, PhD (Vice Chair and Associate Professor) (Vice Chair and Associate Professor)

  4. Northwestern University Feinberg School of Medicine, Evanston, IL, 60201

    Karen L. Kaul MD, PhD (Professor) (Professor)

  5. Department of Pathology and Laboratory Medicine, Evanston Northwestern Healthcare, Evanston, IL, 60201, USA

    Karen L. Kaul MD, PhD (Professor) (Professor)

  6. Molecular Pathology Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania Health System, Philadelphia, PA, 19104, USA

    Vivianna M. Van Deerlin MD, PhD (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hyland, J.C. (2007). Skin and Connective Tissue Disorders. In: Leonard, D.G.B., Bagg, A., Caliendo, A.M., Kaul, K.L., Van Deerlin, V.M. (eds) Molecular Pathology in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-0-387-33227-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-33227-7_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-33226-0

  • Online ISBN: 978-0-387-33227-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation